Stock listing

Stockholm:ALZCUR AlzeCure Pharma AB Aktie

Home listing (Stockholm) of AlzeCure Pharma AB

Follow AlzeCure Pharma AB into a list and get an email when it puts out news.

Share price · OMXSTO:ALZCUR

6.36 SEK -0.04 (-0.6%)

Close on Nov 2, 2026

Past year +194.4% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
6.18 – 6.40 SEKNov 2, 2026
Volume
93,450 sharesNov 2, 2026
Market cap
730.9M SEKAt the close on Nov 2, 2026 · price × 114.9M shares outstanding
52-week range
1.16 – 8.68 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
2.33M SEKMedian day 216,515 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
AlzeCure Pharma AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ALZCUR · Home6.36 SEK-0.04 (-0.6%)93,4506.306.406.186.40Close on Nov 2, 2026
Frankfurt:AC6€0.542 EUR-0.082 (-13.1%)—€0.550€0.550€0.542€0.624Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:ALZCUR · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
6.36-0.04-0.6%6.306.406.1893,450
6.40-0.10-1.5%6.446.526.26114,324
6.50-0.02-0.3%6.506.566.3498,982
6.52+0.06+0.9%6.326.526.12433,126
6.46+0.20+3.2%6.306.506.20203,253
6.26-0.18-2.8%6.406.406.14283,773
6.44-0.14-2.1%6.606.746.08454,193
6.58-0.34-4.9%6.946.946.48255,084
6.92-0.10-1.4%6.987.126.82140,056
7.02+0.06+0.9%6.927.306.86113,246
6.96-0.14-2.0%7.087.086.8684,517
7.10+0.06+0.9%7.107.346.9899,889
7.04-0.08-1.1%7.007.346.94201,484
7.12-0.02-0.3%7.027.246.9484,315
7.14+0.04+0.6%7.107.206.94145,683
7.10+0.34+5.0%6.927.106.62181,353
6.76+0.02+0.3%6.806.866.70172,901
6.74-0.16-2.3%6.846.926.7075,312
6.90+0.10+1.5%6.747.006.70145,287
6.80-0.14-2.0%6.947.086.68130,226
6.94+0.08+1.2%7.027.166.84194,118
6.86-0.40-5.5%7.287.346.86251,392
7.26-0.20-2.7%7.487.487.24158,352
7.46+0.02+0.3%7.327.527.28124,056
7.44+0.12+1.6%7.347.547.24123,747
7.32-0.18-2.4%7.487.587.2690,952
7.50-0.06-0.8%7.567.647.36196,858
7.56+0.04+0.5%7.507.747.20297,875
7.52-0.08-1.1%7.507.747.44177,777
7.60+0.10+1.3%7.567.747.46177,049
7.50-0.24-3.1%7.627.907.50212,763
7.74-0.02-0.3%7.747.967.68211,405
7.76-0.28-3.5%7.988.007.66253,730
8.04+0.04+0.5%8.008.087.86112,454
8.00-0.18-2.2%8.128.147.90211,601
8.180.000.0%8.088.287.96144,768
8.18-0.20-2.4%8.408.568.00386,657
8.38+0.38+4.8%8.108.567.88393,490
8.00-0.44-5.2%8.388.387.98511,041
8.44+0.06+0.7%8.548.688.24449,394
8.38+0.20+2.4%8.228.607.96937,810
8.18+0.04+0.5%8.168.227.94297,193
8.14+0.06+0.7%8.108.267.90621,338
8.08+0.14+1.8%7.948.307.70997,127
7.94+0.56+7.6%7.508.087.36819,223
7.38-0.24-3.1%7.747.787.16442,398
7.62-0.06-0.8%7.688.207.421,316,940
7.68+1.40+22.3%6.307.686.181,950,826
6.28-0.12-1.9%6.506.606.14460,169
6.40+0.16+2.6%6.206.506.10293,409
6.24-0.18-2.8%6.346.346.06321,990
6.42-0.22-3.3%6.606.766.26301,078
6.64-0.06-0.9%6.726.786.56249,104
6.70-0.02-0.3%6.706.806.54167,077
6.72-0.02-0.3%6.746.986.60443,675
6.740.000.0%6.746.846.62146,425
6.74+0.02+0.3%6.766.766.6450,942
6.720.000.0%6.846.846.60149,574
6.72-0.12-1.8%6.847.186.60525,993
6.84+0.12+1.8%6.726.986.70289,894
6.72-0.22-3.2%6.987.006.54262,080
6.94+0.28+4.2%6.647.046.54523,153
6.66+0.10+1.5%6.626.706.48247,048
6.56+0.26+4.1%6.226.726.22424,603
6.30+0.12+1.9%6.146.366.10338,669
6.18+0.10+1.6%6.006.225.80220,267
Ticker
Stockholm:ALZCUR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements

Sep 18, 2026

Closed 7.74 (-0.3%) on Sep 18, 2026

AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15

Sep 8, 2026

Closed 8.44 (+0.7%) on Sep 8, 2026

AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly

Aug 18, 2026

Closed 6.72 (-0.3%) on Aug 18, 2026

AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell

Aug 12, 2026

Closed 6.72 (-1.8%) on Aug 12, 2026

AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell

Aug 3, 2026

Closed 6.18 (+1.6%) on Aug 3, 2026

AlzeCure Pharma Enters an Out-Licensing and Collaboration Agreement with QuantumCell ApS for the NeuroRestore ACD856 Project

Jul 1, 2026

Closed 6.20 (+60.2%) on Jul 1, 2026

Communique from the Annual General Meeting of AlzeCure Pharma on 29 June 2026

Jun 29, 2026

Closed 3.87 (-0.5%) on Jun 30, 2026

AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project

Jun 9, 2026

Closed 4.20 (+246.6%) on Jun 9, 2026

AlzeCure Pharma carries out previously announced rights issue of approximately SEK 30.1 million and publishes information document

Jun 5, 2026

Closed 1.18 (-13.7%) on Jun 5, 2026

Notice To Annual General Meeting in AlzeCure Pharma AB

May 26, 2026

Closed 1.35 (-2.9%) on May 26, 2026

All AlzeCure Pharma AB news

Financings

  • Strategic investment of direct investment in AlzeCure

    Aug 12, 2026

    Closed: US$5M raised · SEK 4.91 a share · Synch Law

    Dealers: Synch Law

    Buyers: QuantumCell ApS (USD 5 million direct investment in AlzeCure)

    Update Aug 3, 2026 · Closed Aug 12, 2026

Read by 6ix AI from the company's releases

Decks

AlzeCure Pharma AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 45 in all · newest Sep 18, 2026 · oldest 2025
Decks
20 decks · latest Sep 17, 2026

Where AlzeCure Pharma AB is listed

ListingExchangeCountryCurrency
Stockholm:ALZCUR · Home listing · This pageStockholmSwedenSEK
Frankfurt:AC6FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about AlzeCure Pharma AB.